Search

everythinglearnresearchcommunity

for

Search:↓

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Finasteride helps reduce priapism in sickle cell anemia patients.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Finasteride helps reduce heart issues and improves heart function.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Female hair loss linked to metabolic syndrome, not in males.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Mice can correct hair follicle orientation without certain genes, but proper overall alignment needs those genes.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The ARTAS robotic system for hair restoration is efficient with fewer cuts than manual methods, but it's limited to certain hair types and can still leave scars.